Stocks
Vanda Pharmaceuticals (VNDA) Debt/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | -11.7 | -11.8 | -9.39 | -50.3 | 34.6 | 11.5 | ||
| Changes by years, y/y, % | +5% | +1% | -20% | +435% | -169% | |||
Vanda Pharmaceuticals. Debt/EBITDA
Vanda Pharmaceuticals. Debt/EBITDA, changes, %
Vanda Pharmaceuticals (VNDA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | -271.3 | 33.9 | 18.5 | 14.3 | 11.5 | 11.5 | ||
| Changes by years, y/y, % | +560% | -163% | -168% | -134% | -104% | |||
| Changes by quarters, q/q, % | +547% | -113% | -46% | -23% | -19% | |||
